ZBH
45
3
AZO
46
-2
MAS
63
3
PVH
30
2
D
45
4
STT
67
2
NWL
57
3
DLTR
58
3
VNO
52
2
SO
53
5
VMC
59
2
EXC
53
3
GS
78
2
ALL
61
-2
KIM
56
5
GIS
54
2
RF
63
2
PLD
33
3
AIV
48
4
MSI
47
-2
ZBH
45
3
AZO
46
-2
MAS
63
3
PVH
30
2
D
45
4
STT
67
2
NWL
57
3
DLTR
58
3
VNO
52
2
SO
53
5
VMC
59
2
EXC
53
3
GS
78
2
ALL
61
-2
KIM
56
5
GIS
54
2
RF
63
2
PLD
33
3
AIV
48
4
MSI
47
-2
Financhill
Back

Sabine Royalty Trust Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
40

SBR
Sabine Royalty Trust

Last Price:
$68.55
Seasonality Move:
4.5%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
40
Sabine Royalty Trust (SBR) is a Sell

Is Sabine Royalty Trust a Buy, Sell or Hold?

  • The current Sabine Royalty Trust [SBR] share price is $68.61. The Score for SBR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • SBR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SBR Stock Price Chart

What is Sabine Royalty Trust's stock price today?

  • The Sabine Royalty Trust share price today is $68.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SBR is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

SBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 17.97 Buy
Relative Strength Index (14 RSI): 37.73 Sell
Chaikin Money Flow: 8194 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.64 - 77.68) Sell
Bollinger Bands (100): (69.48 - 77.56) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

SBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.14 Buy
20-day SMA: 72.05 Sell
50-day SMA: 72.93 Sell
200-day SMA: 69.71 Sell
8-day EMA: 53.15 Buy
20-day EMA: 30.77 Buy
50-day EMA: 14.54 Buy
200-day EMA: 3.97 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Sabine Royalty Trust Earnings Growth & SBR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Sabine Royalty Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):